<p>Research has rekindled interest in the therapeutic power of psychedelics in the clinical treatment of anxiety, depression, and addiction.  Dr. Thomas Cabel and Chad Harman, CEO of Psycheseuticals, explore the status of the field in this revealing interview.</p>

Research has rekindled interest in the therapeutic power of psychedelics in the clinical treatment of anxiety, depression, and addiction. Dr. Thomas Cabel and Chad Harman, CEO of Psycheseuticals, explore the status of the field in this revealing interview.

<p>Research has rekindled interest in the therapeutic power of psychedelics in the clinical treatment of anxiety, depression, and addiction.&nbsp; Dr. Thomas Cabel and Chad Harman, CEO of Psycheseuticals, explore the status of the field in this revealing interview.</p>

Episode 136 -- Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

Inspiration and illumination on the road to recovery.

Share Episode 136 -- Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

Sign up to save your podcasts

Episode 136 -- Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

Episode 136 -- Frontiers of Treatment with Dr. Thomas Cabell and Chad Harman

More shows like Positive Sobriety Podcast

Pirate Monk Podcast